Mark McDonnell

Arch Venture Management, Llc

Assets Managed

$677.094M

Holdings

Last Quarter

2026 - Q1

Filed Date

11d ago

Growth Rate

3.9%(2Q avg: 18.13%)

Sustained Growth

4 quarters

Portfolio positions

This chart displays the top 10 holdings in Arch Venture Management, Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 10 positions.

Assets under management

The assets under management (AUM) of Arch Venture Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 677.094M in assets, with a quarterly growth rate of 3.9% and a 2-quarter average growth rate of 18.13%. The portfolio is managed by Mark McDonnell, and others.

Portfolio holdings

Investment	Portfolio %	Reported Value	Recent Activity
MAZE Maze Therapeutics Inc Recent Activity	18.17%	$122.984M 4.12M shares@ $29.85 avg price
RAPP Rapport Therapeutics Inc Recent Activity	17.24%	$116.672M 3.729M shares@ $31.29 avg price
VIR Vir Biotechnology Inc Recent Activity	17.1%	$115.733M 12.917M shares@ $8.96 avg price
ERAS Erasca Inc Recent Activity Decreased -35.85%	16.95%	$114.741M 7.092M shares@ $16.18 avg price	Decreased -35.85%
BEAM Beam Therapeutics Inc Recent Activity	15.98%	$108.191M 4.54M shares@ $23.84 avg price
LYEL Lyell Immunopharma Inc Recent Activity Increased 17.7%	9.63%	$65.138M 3.247M shares@ $20.07 avg price	Increased 17.7%
GENB Generate Biomedicines Inc Recent Activity New Position	3.59%	$24.305M 1.944M shares@ $12.5 avg price	New Position
TXG 10x Genomics Inc-class A Recent Activity Decreased -70.46%	0.69%	$4.625M 217,834 shares@ $21.24 avg price	Decreased -70.46%
GOSS Gossamer Bio Inc Recent Activity	0.4%	$2.646M 8.056M shares@ $0.33 avg price
QTTB Q32 Bio Inc Recent Activity	0.31%	$2.057M 320,482 shares@ $6.42 avg price

1-10 of 10